Hormone Therapy News

Testosterone treatments given to aging men with obesity, type 2 diabetes and already lowered circulating levels of the hormone did not improve their constitutional or sexual symptoms, according to research published in The Journal of Clinical Endocrinology & Metabolism.

Men with localized prostate cancer who received primary androgen deprivation therapy demonstrated no long-term or disease-specific survival benefit over those who received no treatment, according to results of a retrospective cohort study.

Mayo Clinic and Cleveland Clinic garnered top honors among hospitals for diabetes and endocrinology-related care, as announced today in U.S. News & World Report’s Best Hospitals.

To help manage menopause for women globally, researchers in Melbourne, Australia, created the Practitioner’s Toolkit for Managing the Menopause, published in the International Menopause Society’s journal Climacteric.

CHICAGO — A recently revamped Menopause Map, developed by Endocrine Society physician experts, offers new resources for perimenopausal or postmenopausal women, according to information released at this year’s meeting.

Patients with hypoparathyroidism could achieve mental and physical health improvements with recombinant human parathyroid hormone I-84 therapy, according to research published in The Journal of Clinical Endocrinology & Metabolism.

The FDA is now requiring a general warning on the drug labels of testosterone products about the risk for venous thromboembolism associated with them.

A national sample of men older than 65 years showed no increased risk for myocardial infarction in those who were prescribed testosterone therapy as compared with nonusers, according to study data published today.

CHICAGO — Men with type 2 diabetes and low testosterone levels who were given supplementation with soy protein and phytoestrogens showed significantly improved testosterone levels compared with those given soy protein alone.

CHICAGO — People lacking growth hormone receptors also have an insulin sensitivity that protects against diabetes and decreases cancer risks, according to research presented at the joint meeting of the International Congress of Endocrinology and the Endocrine Society.